© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cefathiamidine traces its roots back to the 1970s during a busy period for beta-lactam antibiotic discovery. Chinese researchers—backed by deep expertise in microbial fermentation and cephalosporin modification—first synthesized this drug to answer an unmistakable problem: harsh infections in hospitals, especially from gram-positive bacteria. Over time, medical practitioners leaned on cefathiamidine when penicillins stumbled due to resistance or allergy issues. A step forward in cephalosporin innovation in China, it represented a homegrown solution at a time when most antibiotics reached the country from foreign companies. As resistance rates soared in the following decades, hospitals continued to look for reliable options, keeping drugs like cefathiamidine in everyday use across clinics from Beijing to rural county seats.
Cefathiamidine stands as a semi-synthetic, first-generation cephalosporin. Its place is mainly in treating infections caused by susceptible gram-positive bacteria, such as Staphylococcus and Streptococcus species. The product, typically formulated as a dry powder for injection, often fills that critical gap when standard beta-lactam therapies fail or are contraindicated. In China, pharmacists and physicians see cefathiamidine as a workhorse for pediatric and adult care—a reputation earned through steady performance and a manageable safety profile. Given its track record, hospitals keep it on hand for skin, soft tissue, and some respiratory infections.
Looking at cefathiamidine under the microscope, you find a white to slight yellow crystalline powder. It dissolves in water with a little agitation but resists mixing in alcohol and organic solvents—exactly what one expects from a cephalosporin. Molecular formula C16H17N7O4S3, molecular weight hovers around 487.55 g/mol. Chemically stable under refrigeration, the product degrades in the presence of high heat or strong alkaline conditions. The smell is faint to nearly absent, and solutions remain stable at neutral to slightly acidic pH. Careful storage preserves potency, echoing the attention to detail at every step, from factory line to pharmacy shelf.
A typical vial contains cefathiamidine hydrochloride equivalent to 1.0g or 2.0g of active ingredient. The compounding processes guarantee high purity, minimal pyrogen content, and tight particle size distribution—essential for safe intravenous administration. Labels must list batch number, production and expiration dates, and storage instructions. Besides regulatory compliance, these labels provide Chinese clinicians streamlined data for rapid reference during hospital rounds. Strict quality control measures force every lot through assays for content, related substances, and sterility. Shelf life averages 24 months when kept cool and dry. In recent years, major manufacturers in China have pushed for more user-friendly packaging to meet busy hospital environments.
Cefathiamidine production starts with the fermentation of a suitable Cephalosporium strain to yield cephalosporin C. Purified cephalosporin undergoes chemical modification, where the thiazolylamidino side chain is introduced via amidination, followed by acylation to afford the final cephalosporin nucleus. Carefully tuned reaction conditions avoid byproducts and maximize efficiency. Recrystallization, filtration, and vacuum-drying steps produce a high-purity, sterile powder suitable for medical use. Large-scale batch production relies on automated controls and experienced chemical engineers who troubleshoot problems before they reach the quality control lab.
The cephalosporin scaffold is a busy playground for chemists. In cefathiamidine’s case, the key chemical trick is placing an amidino group on the 7-position, which grants the drug decent stability against certain beta-lactamases and boosts its gram-positive spectrum. Minor changes in the reaction steps or reagents directly influence yield and purity, making process control essential. Research teams have explored similar modifications to improve activity further or inject new spectrum profiles, sometimes swapping out the thiamidine group for other nitrogen-based linkers in search of more potent analogs. Breakthroughs have so far come in small steps rather than leaps, with every tweak potentially influencing toxicity, solubility, or cost.
Pharmacies and chemical catalogs list cefathiamidine by several names. Its Chinese innovation roots mean its brand names skew toward Mandarin or Pinyin conventions. Most common within China: Sefatiuming, 明舒 or Xuehuiming. International databases log it under cefathiamidine hydrochloride, along with the original research code numbers like CS-749. Researchers looking for substance clarity stick with the IUPAC nomenclature: (6R,7R)-7-[2-(2-thiazolyl)acetamido]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Whether physicians are searching clinical trial results or hospital pharmacy procurement records, the context behind the name shapes the usage.
Drug safety defines modern hospital protocols, and cefathiamidine is no exception. Before use, care teams screen for life-threatening beta-lactam allergies and always have resuscitation equipment nearby just in case. Dosage and infusion rates fit strict guidelines depending on patient age, weight, and kidney function. Hospitals only mix the injection right before use to preserve chemical integrity. Any unused solution gets discarded, following rules for hazardous pharmaceutical waste. Workers handling bulk product wear gloves and masks due to the chance of allergic or hypersensitivity reactions upon skin or inhalation exposure. Clinical pharmacists check orders twice, watching out for drug interactions—with warfarin, aminoglycosides, or loop diuretics at the top of the list. As with all antibiotics, stewardship programs push doctors to use cefathiamidine judiciously to prevent resistance.
Cefathiamidine’s real-world use centers in hospital wards—pediatric, surgical, and infectious disease clinics. Doctors turn to it for community-acquired pneumonia, skin abscesses, bone and joint infections, and some post-surgical prophylaxis, especially for patients at risk from common gram-positive bacteria. Chinese practice guidelines mention it often, and hospitals in major cities and rural areas report decades of collective experience managing its side effect profile. New uses—like treating resistant pathogens or for patients intolerant of other cephalosporins—are sometimes explored, but most evidence supports its main indication as a go-to in early infection management. Combination therapies rarely feature cefathiamidine, as the spectrum fits best in mono-therapy settings.
Scientists still study cefathiamidine’s mechanism of action, looking deeper into how it binds to penicillin-binding proteins and how small mutations in these proteins affect clinical success rates. Researchers monitor resistance trends using surveillance data from thousands of hospital labs, feeding into global networks that flag shifts in susceptibility. New derivative compounds—modifying the thiazolyl ring or the side chains at positions 3 and 7—remain an active field for medicinal chemists hoping to widen the drug’s spectrum or cut toxicity. Several university labs in China are working to translate in-vitro potency into clinical candidates that move beyond the original scaffold, but progress takes constant funding and regulatory patience.
Toxicology studies show cefathiamidine holds a safety margin in line with other first-generation cephalosporins. The main adverse effects come from hypersensitivity reactions—rash, urticaria, or, in rare cases, anaphylaxis. Kidney function monitoring is part of routine protocol, especially with high doses or in vulnerable groups like children and the elderly. Animal studies and post-market hospital surveillance have not flagged unusual organ toxicity. Gastrointestinal upset or mild local irritation at injection sites are the effects most cited in patient surveys. Modern pharmacovigilance programs track adverse event reports in real time, so researchers remain alert to rare but serious syndromes like neutropenia, which have cropped up with broader cephalosporin use.
Healthcare systems in Asia continue to rely on cefathiamidine, especially with rising antibiotic resistance threatening even advanced, high-cost drugs. Researchers see potential in new formulations—long-acting injectables or oral solid forms—which could make the drug more flexible outside hospital settings. Genetic engineering of production strains may reduce costs, offering safer, more stable products. Many scientists agree that a stronger focus on resistance patterns and stewardship may preserve cefathiamidine’s usefulness for decades. For now, Chinese pharmaceutical firms and public health authorities keep investing in studies that track efficacy, safety, and resistance, aiming to keep this homegrown antibiotic a trusted weapon in routine medical practice.
Growing up in a family where medical conversations filled the dinner table, I learned early how antibiotics play a vital role against bacterial diseases. Cefathiamidine, a first-generation cephalosporin antibiotic, carries particular relevance in healthcare settings across Asia, especially in China. Hospitals there rely on it for a range of infections. Whether it’s battling respiratory infections, urinary tract issues, or tackling skin wounds that struggle to heal, this drug often shows up as a practical choice.
My time volunteering in a community clinic exposed me to stories behind the prescription. Many patients presenting with fever and fatigue left with a cefathiamidine prescription when rapid lab results suggested a bacteria-driven illness. Doctors often pick it because it covers a variety of bacteria and usually gets the job done before things get more complicated.
Doctors cannot help but notice that bacteria keep finding clever ways to dodge antibiotics. Cefathiamidine isn’t immune to this problem. In some hospitals, strains of Escherichia coli and Klebsiella pneumoniae—two frequent culprits behind infections—have built up resistance over time. A study published in the Journal of Infection and Chemotherapy (2023) flagged that up to 20% of these bacteria dodged the drug in some areas. That means doctors must weigh their options carefully. Resorting to cefathiamidine works best after confirming the bacteria’s susceptibility, often through a lab culture.
This ongoing tug-of-war reveals a bigger truth about how antibiotics like cefathiamidine fit into daily practice. Experience shows that pharmacists and clinicians hold the line by closely tracking resistance data and keeping prescriptions tailored to proven cases. My pharmacist friends tell me that over-the-counter requests for antibiotics remain stubbornly high, but without careful oversight the effectiveness of drugs like cefathiamidine could quickly slip away.
With all medicines come benefits and risks, and cefathiamidine doesn’t escape that rule. Most people tolerate it well, though side effects like rashes, stomach upset, or shifts in white blood cells pop up now and then. I remember one night shift in the clinic when a patient reported a sudden rash after an antibiotic injection. Our team caught it early, stopped the medication, and switched gears safely. Mild allergic responses are more common than severe ones, but even mild side effects deserve a quick response to keep patients safe.
Nothing replaces practical experience when deciding how and when to use cefathiamidine. Taking a page from infectious disease experts, they emphasize regular education for prescribers so that antibiotics only go to those who truly benefit. Hospitals that set up stewardship programs and run surveillance on resistance patterns stand a better chance at preserving antibiotic power.
Better stewardship isn’t just about tighter rules. It comes from open discussions, strong patient education, and transparency about the risks of overuse. I have seen firsthand that when patients hear the real reasons for antibiotic limits, most accept careful use—for themselves and for public health. That keeps cefathiamidine in the toolbox when the next tough infection comes along.
A lot of people put strong faith in antibiotics to fix infections. Cefathiamidine belongs to the cephalosporin family. It’s one of those drugs often used in hospitals, especially across China. Doctors reach for it in treating all sorts of bacterial issues, from pneumonia to blood infections. If someone wants to know what the possible side effects are, it shouldn't feel like decoding hidden medical riddles.
Talking about antibiotics always brings me back to my mother’s medicine cabinet. She didn’t like surprises, especially health ones. Every time an antibiotic showed up at our house, she made sure everyone knew what to expect. Cefathiamidine isn't much different from other antibiotics in some ways, but the details matter. Common side effects pop up most in digestive systems. Lots of folks report stomach upset, a queasy feeling, cramps, sometimes outright diarrhea. These aren’t rare. I’ve heard from nurses that stomach issues sometimes make patients give up half-way, risking resistance.
Allergic reactions show up too. Rashes, itching, and hives can happen. In more extreme cases, swelling hits the lips or throat and breathing gets tough—a situation that becomes a medical emergency. I have seen people shrug off a little rash, not knowing things might escalate quickly. For anyone with a history of harmful reactions to other cephalosporins or penicillin, extra caution means everything.
There are some side effects that rarely knock on the door but pack a punch when they do. Blood cell counts sometimes drop, leaving a person vulnerable to infections or strange bruising. Some patients get headaches, dizziness, or changes in taste. Liver enzymes may spike—bloodwork will tell the truth if anyone really looks. One teenager I met had mild jaundice from medication, and doctors acted quickly after seeing his yellow-tinted skin. That story stuck with me because it happened over a weekend, when fewer staff were around.
Antibiotics like cefathiamidine can knock out healthy bacteria too, not just the bad guys. That opens doors for fungal infections or digestive troubles well after finishing the prescription. Someone might notice odd mouth sores or a new bout of diarrhea several days later. Science backs up these risks. Studies from Chinese hospitals found digestive troubles in up to one in ten patients, with allergic rashes happening a little less often.
Nobody wants to hear stories of worsening infections because someone feared a rash. At the same time, side effects are serious, especially when a patient is young, frail, or dealing with other illnesses. Taking antibiotics without a real need or starting and stopping based on side effects both cause real harm. Regular conversations between patients and clinicians build trust and keep surprises at bay.
Asking questions, reading drug sheets, and reporting even mild reactions early helps. Doctors can swap drugs, adjust doses, or track changes with blood tests. If health workers get honest about the risks and support patients through bumps in the road, the benefit of antibiotics like cefathiamidine stays within reach without the shadow of hidden dangers.
Doctors often turn to antibiotics like cefathiamidine to bring bacterial infections under control. With resistant bugs becoming a bigger headache in clinics worldwide, it’s tough to pick the right medicine and use it properly. Cefathiamidine isn’t something anyone swallows without guidance. It comes as a powder for injection, and nobody takes it by mouth. Skilled hands measure the exact dose, mix it with a sterile solution, and give it either as a shot into the muscle or an intravenous drip.
In medicine, too much or too little can wreck the results patients need. Doctors work out the total dose by checking age, body weight, how well the kidneys clear drugs, and how severe the infection has gotten. Not long ago, I saw a neighbor’s child rushed in with a fever and a cough that didn’t quit. Their pediatrician called for blood tests, found a serious lung bug, and pushed the hospital pharmacist for exact dosing. Mistakes happen if nurses or families guess at the right amount—or if they use leftovers from someone else, which creates danger for resistant infections and allergic reactions.
You’ll never see cefathiamidine in pharmacies for home use. That’s for a reason. It demands precise mixing, clean technique, and tracking for bad effects. Giving injections without enough know-how leads to infections that could send people back to an emergency room. I’ve seen parents ask for leftover antibiotics ‘just in case.’ Every professional I know says no to that. Self-medicating with injectable antibiotics is a one-way street to trouble—rashes, kidney issues, unpredictable side effects, and a real risk that bacteria get more resistant. The medical world already faces enough problems with drugs becoming less useful, so each dose must count.
In hospital settings, teams follow guidelines—they don’t eyeball doses. World Health Organization and national medical groups publish updates about effective dosing strategies, and hospital pharmacists keep close tabs on what’s going into each patient. That’s not just for paperwork—tracking avoids mix-ups and protects patients who may not know if they have allergies or kidney trouble. Cefathiamidine ends up chosen for certain bugs because of how it fights off the bacteria’s cell wall. Still, doctors won’t use it when a pill might do the job or when the infection doesn’t call for such a tool.
Too many parts of the world deal with antibiotics handed out without proper checks. That’s how drug resistance spreads and how people end up with bills for hospital stays that could have been avoided. Nurses, doctors, and pharmacists get extra training for these drugs, and hospitals run regular audits to catch slip-ups early. Teaching families why injections like cefathiamidine demand a trained professional isn’t always simple. It starts with honest conversation and public awareness. If governments spend to educate health workers and tighten up sales, far fewer people will end up harmed by misuse. Responsible care protects everyone in the long run.
Cefathiamidine, a cephalosporin antibiotic, holds a spot in many hospitals across East Asia. Used to fight a range of bacterial infections, it serves its purpose well. But no drug works in a vacuum. Every medicine comes with its own set of rules, and Cefathiamidine is no exception.
If you’ve got an allergy to penicillins or any cephalosporins, it’s best to speak up before taking Cefathiamidine. Cross-reactivity happens because the structure of these drugs looks similar under a microscope. Rashes, hives, swelling, or even life-threatening reactions like anaphylaxis have been recorded over the years. For folks already allergic to this family of drugs, exposing the body a second time risks more severe symptoms. Doctors usually want to dig into your medical history before the prescription gets filled for good reason.
Renal function matters too. The kidneys are put in charge of clearing the drug from the system. People living with kidney problems may hold onto Cefathiamidine longer than planned, leading to toxicity—think seizures or confusion. In these cases, labs might guide dose adjustments to keep the drug out of the danger zone. Adding in another medicine that stresses the kidneys, like some diuretics or painkillers, can make problems worse.
Some meds just do not play well together. Aminoglycosides, famous for their strong antibiotic punch, can hurt the kidneys or hearing. Combine them with Cefathiamidine, and the risk steps up. Carefully tracking what’s in your medicine cabinet can help prevent trouble. Hospitals have pharmacists on board for this exact reason—they double-check, and it’s saved plenty of folks from a nasty surprise.
Mixing with alcohol or certain anticoagulants can also twist the body’s response to the antibiotic. Some cephalosporins trigger something called a disulfiram-like reaction with alcohol, bringing on nausea, flushing, and pounding headaches. For blood thinners, bleeding risks could climb unexpectedly high, especially in those with existing health issues. Labs and honest medical conversations can guide whether this antibiotic is the best pick.
Age brings its own concerns. Children’s bodies process medication differently, and dosing needs a personalized approach to avoid under-treatment or toxicity. Research on pediatric safety isn’t as rich as in adults, but decades of experience have shown that dosing by weight and careful monitoring cuts problem rates down.
Elderly patients can face a tougher road. Changes in kidney function and a long list of other medications create an environment primed for interactions or accidental overdose. Physicians tend to start low and move slow, especially if confusion or new health complaints crop up soon after therapy begins.
Doctors and pharmacists rely on open communication with patients. No one can guess a hidden allergy or symptom repeat from a prior illness unless the information comes up. Patients have a role too. Sharing full medical history, recent test results, and all medicines (including over-the-counter and herbal remedies) makes treatment safer. Challenges around antibiotic resistance are real—infections adapt, and drugs lose punch—so sticking to prescribed doses and finishing the full course matters for everyone.
Modern medicine has solved a lot of puzzles, but real safety comes from teamwork between patients and healthcare teams. Stepping into a clinic with questions, and checking in with your own body, helps keep Cefathiamidine helpful and not harmful.
Cefathiamidine belongs to the cephalosporin family of antibiotics, often given for bacterial infections. For many people, antibiotic selection feels routine, but pregnancy and breastfeeding change that landscape. Every new medicine brings another layer of worry, especially with limited research. I’ve sat across from expectant mothers who have real concerns about treating infections but don’t want a decision to backfire on their baby’s safety or their own health.
Doctors lean on safety data for guidance, but cefathiamidine’s file runs thin. Animal studies haven’t flagged major problems for developing fetuses, yet clear evidence in humans is missing. Clinical guidelines usually recommend older antibiotics—amoxicillin, for example—since we know much more about their safety. Cefathiamidine doesn’t have that kind of track record.
The World Health Organization and most national health services stress the importance of only using antibiotics during pregnancy when really necessary, and only after checking that safer alternatives don’t fit the situation. For breastfeeding mothers, pieces of evidence show cephalosporins can enter breast milk in small amounts. Most reports suggest the baby’s risk from exposure is low, but vigilance around diarrhea, thrush, or allergic reactions matters.
Infections during pregnancy, like urinary tract infections or pneumonia, are serious for both mom and baby. Untreated infections have caused more problems in my clinic than the rare, possible side effects of antibiotics. So, risk isn’t just about the medicine; it’s also about what happens if an infection runs wild. Doctors have to weigh the urgency of the infection against the risk, all while remembering there aren’t many large studies on cefathiamidine specifically in these situations.
Here’s what experience in the medical office teaches. Ask questions about the medication. Is there a safer or better-studied alternative? Was the infection confirmed by lab tests? Are there local resistance patterns that make cefathiamidine the right tool for the job? Never feel pushback about wanting straight answers before taking a medicine during pregnancy or while breastfeeding.
Pay attention to how you and your baby feel. If your doctor prescribes cefathiamidine, make it a point to watch for rashes, digestive upset, diaper changes, or signs of discomfort in your child. Reporting problems early helps everyone make wiser choices for future care.
Antibiotic policies grow out of piles of research data and lived patient experiences. More studies about cefathiamidine could help families and doctors make stronger, more confident choices. Until those studies turn up, leaning into conversations with physicians and keeping close watch on outcomes is the safest path. If you do need an antibiotic, only take it after a full discussion of the risks and benefits with a knowledgeable healthcare provider.
Practicing medicine is about making hard decisions with the best available info. For now, the decision to use cefathiamidine with pregnancy or breastfeeding still rests on careful judgment, experience, and a willingness to advocate for yourself and your child.
| Names | |
| Preferred IUPAC name | (6R,7R)-3-[(2E)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-7-[[(2R)-2-(aminomethyl)thiazol-4-yl]thio]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Other names |
Cephathiamidine Thiamidinecephalosporin |
| Pronunciation | /ˌsɛfəˌθaɪəˈmaɪdɪn/ |
| Identifiers | |
| CAS Number | 65052-63-3 |
| Beilstein Reference | 3526739 |
| ChEBI | CHEBI:131729 |
| ChEMBL | CHEMBL2106029 |
| ChemSpider | 160012 |
| DrugBank | DB13325 |
| ECHA InfoCard | 100.119.787 |
| EC Number | EC 259-453-6 |
| Gmelin Reference | 106078 |
| KEGG | D07275 |
| MeSH | D002495 |
| PubChem CID | 6918493 |
| RTECS number | RI0350000 |
| UNII | G6T8DT71WQ |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C16H17N7O4S2 |
| Molar mass | 538.0704 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.8 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.5 |
| Vapor pressure | 6.33E-18 mmHg at 25°C |
| Acidity (pKa) | 2.31 |
| Basicity (pKb) | 2.64 |
| Dipole moment | 5.51 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Cefathiamidine is 510.3 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4597 kJ/mol |
| Pharmacology | |
| ATC code | J01DB11 |
| Hazards | |
| Main hazards | May cause allergic reactions; avoid inhalation, ingestion, and contact with skin or eyes. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Store at temperature not exceeding 20°C. Keep out of reach of children. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > Flash point: 228.8 °C |
| LD50 (median dose) | LD50 (median dose) of Cefathiamidine: "i.v. in mice: 12.0 g/kg |
| NIOSH | Not Listed |
| PEL (Permissible) | 0.03 mg/m³ |
| REL (Recommended) | 2 g |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Cephalexin Cephradine Cefazolin Cefaloridine |
